Oct 12 (Reuters) - Mithra Pharmaceuticals SA MITRA.BR :
* MITHRA ANNOUNCES POSITIVE PRECLINICAL DATA DEMONSTRATING
ESTETROL'S EFFICACY IN WOUND HEALING
* ROBUST MECHANISM OF ACTION DATA SHOW THAT ESTETROL
IMPROVES
WOUND CLOSURE AND DAMPENS LOCAL INFLAMMATION, SUPPORTED BY A
UNIQUE GENE SIGNATURE, COMPARED TO OTHER ESTROGENS
* DEVELOPMENT OF A NOVEL ESTETROL FORMULATION FOR TOPICAL
APPLICATION IS ONGOING, WITH POTENTIAL BENEFIT IN BOTH ACUTE AND
CHRONIC WOUND SETTINGS
* CLINICAL PROGRAM IS EXPECTED TO BE LAUNCHED IN H2 OF 2023
WITH
PUNCH BIOPSY STUDY AIMED TO EXPLORE SAFETY AND EFFICACY OF
MITHRA’S E4 TOPICAL LEAD FORMULATION
Further company coverage: MITRA.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))